DMSO_A_226056 2441..2451

*These authors contributed equally to this work Background: Pituitary adenoma (PA) is a prevalent intracranial tumor. Metabolites differ between pituitary tumor and healthy tissues or among different tumor subtypes. However, the transcriptional changes in metabolic enzymes, which are usually seemed as targets for metabolic therapy, remain unidentified. Methods: Using microarray data for 160 samples from the Gene Expression Omnibus database, across the four most common tumor subtypes, we present the integrated identification of differentially expressed genes (DEGs) between tumors and controls. Results: Subtype-specific DEGs revealed 1081 prolactin tumor-specific DEGs, 437 nonfunctioning tumor-specific DEGs, and 217 common DEGs among the four subtypes. Functional enrichment showed that a lot of biological functions related to metabolism had changed. Twenty-one prolactin and twenty-three nonfunctioning tumor-specific metabolicrelated DEGs are mainly involved in fatty acid and nucleotide metabolism, redox reaction, and gluconeogenesis. Eighteen metabolic-related DEGs enriched in the metabolism of xenobiotics by the cytochrome P450 pathway, sulfur metabolism, retinoid metabolism, and glucose homeostasis were abnormal in all subtypes of PA. Conclusion: Based on a comprehensive bioinformatics analysis of the available PA-related transcriptomics data, we identified specific DEGs related to metabolism, and some of them might be new attractive therapeutic targets. Especially, PDK4 and PCK1 might be new attractive biomarkers and therapeutic targets.

[1]  F. Kuchenbauer,et al.  Extracellular matrix components regulate ACTH production and proliferation in corticotroph tumor cells , 2001, Molecular and Cellular Endocrinology.

[2]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[3]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[4]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[5]  Shereen Ezzat,et al.  The prevalence of pituitary adenomas , 2004, Cancer.

[6]  F. Kuchenbauer,et al.  Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[8]  Simon Tavaré,et al.  beadarray: R classes and methods for Illumina bead-based data , 2007, Bioinform..

[9]  J. Lebrun.  Activin, TGF-beta and menin in pituitary tumorigenesis. , 2009, Advances in experimental medicine and biology.

[10]  Péter Csermely,et al.  Protein-Protein Interaction Networks , 2009, Encyclopedia of Database Systems.

[11]  A. Grossman,et al.  Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis , 2009, Expert opinion on therapeutic targets.

[12]  Hanbo Chen,et al.  VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R , 2011, BMC Bioinformatics.

[13]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[14]  M. Geraci,et al.  Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. , 2011, Endocrinology.

[15]  Michael Kohl,et al.  Cytoscape: software for visualization and analysis of biological networks. , 2011, Methods in molecular biology.

[16]  Ibrahim Emam,et al.  ArrayExpress update—an archive of microarray and high-throughput sequencing-based functional genomics experiments , 2010, Nucleic Acids Res..

[17]  N. Oyesiku,et al.  Genomic characterization of human and rat prolactinomas. , 2012, Endocrinology.

[18]  J. Bollerslev,et al.  Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly. , 2012, The Journal of clinical endocrinology and metabolism.

[19]  O. Stoeltzing,et al.  STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases. , 2012, Neoplasia.

[20]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[21]  E. Arvat,et al.  Potential role for retinoic acid in patients with Cushing's disease. , 2012, The Journal of clinical endocrinology and metabolism.

[22]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[23]  Xinxia Peng,et al.  The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease , 2014, Nature Biotechnology.

[24]  T. Seyfried,et al.  Cancer as a metabolic disease: implications for novel therapeutics , 2013, Carcinogenesis.

[25]  Zachary A. King,et al.  Constraint-based models predict metabolic and associated cellular functions , 2014, Nature Reviews Genetics.

[26]  T. Tateno,et al.  The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas. , 2014, Endocrine-related cancer.

[27]  Shengyuan Yu,et al.  Identification of Differentially Expressed Genes in Pituitary Adenomas by Integrating Analysis of Microarray Data , 2015, International journal of endocrinology.

[28]  T. Roskams,et al.  Pituitary tumors contain a side population with tumor stem cell-associated characteristics. , 2015, Endocrine-related cancer.

[29]  Shengyuan Yu,et al.  Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas , 2016, Tumor Biology.

[30]  Fátima Sánchez-Cabo,et al.  GOplot: an R package for visually combining expression data with functional analysis , 2015, Bioinform..

[31]  Xiaoyu Liang,et al.  Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors. , 2015, Cancer research.

[32]  S. Melmed,et al.  STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion. , 2015, The Journal of clinical investigation.

[33]  L. Vilar,et al.  The Role of Isotretinoin Therapy for Cushing's Disease: Results of a Prospective Study , 2016, International journal of endocrinology.

[34]  M. de Castro,et al.  Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas , 2017, Front. Endocrinol..

[35]  M. Molitch.  Diagnosis and Treatment of Pituitary Adenomas: A Review , 2017, JAMA.

[36]  Matthew G. Vander Heiden,et al.  Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.

[37]  C. Sapienza,et al.  Oncogenic role of PDK4 in human colon cancer cells , 2017, British Journal of Cancer.

[38]  Bo Li,et al.  NOREVA: normalization and evaluation of MS-based metabolomics data , 2017, Nucleic Acids Res..

[39]  Silin Wu,et al.  Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile , 2017, Biochemical Genetics.

[40]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 , 2017, Neuro-oncology.

[41]  Hui Yang,et al.  Lactate dehydrogenase A promotes the invasion and proliferation of pituitary adenoma , 2017, Scientific Reports.

[42]  D. Smiraglia,et al.  Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas , 2018, Nature Communications.

[43]  W. Rui,et al.  Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours , 2018, Nature Communications.

[44]  M. Korbonits,et al.  Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland , 2018, Oncotarget.

[45]  M. Losa,et al.  Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles , 2018, Journal of neuroendocrinology.

[46]  M. Dattani,et al.  Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation , 2018, Nature Communications.

[47]  H. Link,et al.  Crosstalk between transcription and metabolism: how much enzyme is enough for a cell? , 2018, Wiley interdisciplinary reviews. Systems biology and medicine.

[48]  O. Pînzariu,et al.  Metabolomics—A Promising Approach to Pituitary Adenomas , 2019, Front. Endocrinol..

[49]  Miaolong Lu,et al.  The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas , 2019, Front. Endocrinol..

[50]  T. Jacques,et al.  Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ , 2018, Endocrine-related cancer.

[51]  S. Kopriva,et al.  Sulfation pathways from red to green , 2019, The Journal of Biological Chemistry.

[52]  Yuqi Gao,et al.  Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma , 2019, Front. Oncol..

[53]  Shehua Qian,et al.  Quantitative Analysis of Ubiquitinated Proteins in Human Pituitary and Pituitary Adenoma Tissues , 2019, Front. Endocrinol..

[54]  Bo Li,et al.  Consistent Biomarkers and Related Pathogenesis Underlying Asthma Revealed by Systems Biology Approach , 2019, International journal of molecular sciences.